The Best Research participation opportunities in clinical trials in Minneapolis, Minnesota

The Minneapolis Heart Institute - Genetic Arrhythmia Center, located at 800 East 28th Street in Minneapolis, Minnesota, is a specialized institution dedicated to serving patients and families affected by rare genetic heart conditions. This center provides hope, answers, and prevention strategies to avoid life-threatening events in family members. The Genetic Arrhythmia Center offers a unique opportunity for researchers to study genetic disorders that are not well understood and have uncertain treatment options. These disorders can result in sudden cardiac arrest and death, often going undetected until a life-threatening event occurs. Due to their rarity, little is known about these conditions, and many cardiologists may only encounter a few cases throughout their career.

The University of Minnesota Physicians Pediatric Dental Clinic is a state-of-the-art facility located at 701 25th Avenue South in Minneapolis, Minnesota. This clinic, made possible by Delta Dental of Minnesota, offers high-quality dental care for children with a variety of needs, including complex cases, medically-compromised patients, and those with special health needs or anxiety. The clinic features 14 chairs, including open-bay stations and private treatment rooms equipped with advanced patient monitoring technology. It is fully integrated with the University of Minnesota Masonic Children's Hospital, which is recognized for its top-ranked specialties by U.S. News & World Report.

Allina Health Minneapolis Heart Institute – Woodbury is a leading healthcare institution located at 8675 Valley Creek Road in Woodbury, Minnesota. Our team of dedicated cardiologists, clinical scientists, registered nurses, and regulatory specialists collaborate to find innovative solutions for preventing and treating cardiovascular disease. One of the key aspects of our institution is our focus on clinical trials, which provide patients with the opportunity to actively participate in their healthcare, access cutting-edge drugs and treatments, and contribute to the advancement of medical research. By participating in clinical trials at Allina Health Minneapolis Heart Institute – Woodbury, patients can play a crucial role in improving the understanding and management of cardiovascular conditions.

The UMN College of Pharmacy Duluth Campus is located at 1110 Kirby Drive in Duluth, Minnesota, United States. As part of the University of Minnesota College of Pharmacy, the Duluth Campus offers a range of pharmacy programs and research opportunities. With a focus on research ethics, the institution is dedicated to protecting research participants, upholding ethical standards, and continuously improving their practices. For general information, inquiries can be directed to 218-726-6000 or copd@d.umn.edu. The campus also has a Twin Cities location at 308 Harvard Street SE in Minneapolis, with contact information available at 612-624-1900 or pharm@umn.edu. Visit the campus map for more details on the locations of both campuses.

James B. Hoelzle, PHD is a health institution located at 1 Veterans Drive in Minneapolis, Minnesota, United States. As part of the Minneapolis VA Health Care System, our experienced health care teams are dedicated to meeting the needs of Veterans, their families, and caregivers. Our secure website allows for online health management, community event sign-ups, and updates. Caregivers of Veterans can also participate in video chat sessions focused on self-care. Join us as we work together to provide exceptional care and support to those who have served our country.

The Institute for Therapeutics Discovery and Development, located at 717 Delaware Street Southeast in Minneapolis, Minnesota, is a leading institution dedicated to advancing pioneering research in drug discovery and early pre-clinical drug development. Collaborating with various schools, colleges, and research centers, as well as industrial partners nationwide, the institute creates opportunities for groundbreaking discoveries in the field of pharmaceutical sciences. One of the notable achievements of the institute includes the development of YCT-529, a hormone-free male birth control pill, which has shown promising results in clinical trials. Additionally, the institute has been involved in the successful Phase 2 clinical trials of glaucoma drug QLS-101, demonstrating a favorable safety profile and efficacy signal.